About The Author

Richard Mollard is the Chief Scientific Officer at PharmAust. Dr Richard Mollard received a PhD in 1996 from Monash University and an MBA in 2006 from Melbourne Business School in conjunction with the University of St Gallen, Switzerland. Dr Mollard has held scientific positions in France, the US and Australia working with: University Louis Pasteur/ IGBMC, Bristol Myers Squibb, University of Michigan, Eli Lilly & Co and Monash University. Dr Mollard has further previously consulted in business development and technical diligence for ASX listed companies such as Agenix Ltd, Immuron Ltd, PharmAust Ltd, and Regeneus Ltd as well as being founder, executive and consultant with biotech startup companies working in Australia, China, Hong Kong, Japan, Malaysia, Vietnam, Thailand and Singapore.